利妥昔单抗治疗小儿重型自身免疫性溶血性贫血2例分析

利妥昔单抗治疗小儿重型自身免疫性溶血性贫血2例分析

管玉洁,刘炜,李彦格

郑州市儿童医院血液科,郑州市儿童医院血液科,郑州市儿童医院血液科

收稿日期:2013-05-23 修回日期:2013-06-23 出版日期:2013-06-25 发布日期:2013-06-24

Durable Remission Treatment with Rituximab in Two Pediatric Patients with Severe Refractory Autoimmune Hemolytic Anemia

刘炜 and

Department of Hematology,Zhengzhou Children’s Hospital,Department of Hematology,Zhengzhou Children’s Hospital,Department of Hematology,Zhengzhou Children’s Hospital

Received:2013-05-23 Revised:2013-06-23 Online:2013-06-25 Published:2013-06-24

摘要/Abstract

摘要： 利妥昔单抗在儿童自身免疫性溶血性贫血(AIHA)中的应用目前国内鲜见相关报道，仅见有限的成人AIHA应用案例。作为靶向治疗药物，国外已广泛应用于难治性或复发性自身免疫性疾病中。现对我院应用利妥昔单抗成功治疗儿童难治性重型AIHA 2例进行临床分析，以期为临床儿童用药提供参考。

管玉洁,刘炜,李彦格. 利妥昔单抗治疗小儿重型自身免疫性溶血性贫血2例分析[J]. .

刘炜 and. Durable Remission Treatment with Rituximab in Two Pediatric Patients with Severe Refractory Autoimmune Hemolytic Anemia[J]. .

[1] 王天有,刘子勤.儿童自身免疫性溶血性贫血的进展[J].中国小儿血液与肿瘤杂志,2010, 15:1-2.
[2] 陈琪,平宝红,周淑芸,等.CD20嵌合型单抗美罗华治疗自身免疫性溶血性贫血[J].中华临床医药杂志,2003,4:53-54.
[3] 陈婷,张曦,张诚,等.美罗华治疗老年自身免疫性溶血性贫血的临床研究[J].国际检验医学杂志,2011,32:1199.
[4] Michel M. Classification and therapeutic approaches in autoimmune hemolytic anemia: an update[J]. Expert Rev Hematol,2011,4:607-618.
[5] Valent P,Lechner K. Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review[J].Wien Klin Wochenschr,2008,120:136-151.
[6] Berentsen S, Sundic T, Hervig T,et al. Autoimmune hemolytic anemia[J].Tidsskr Nor Laegeforen,2009,129:2226-2231.
[7] Abdulla NE,Ninan MJ,Markowitz AB. Rituximab:current status as therapy for malignant and benign hematologic disorders[J].BioDrugs,2012,26:71-82.
[8] Barros MM,Blajchman MA,Bordin JO. Warm autoimmune hemolytic anemia:recent progress in understanding the immunobiology and the treatment[J]. Transfus Med Rev, 2010,24:195-210.
[9] Stasi R. Rituximab in autoimmune hematologic diseases:not just a matter of B cells[J].Semin Hematol,2010,47:170-179.
[10] Rao A,Kelly M,Musselman M,et al. Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias[J].Pediatric Blood Cancer,2008,50:822-825.
[11] Garvey B. Rituximab in the treatment of autoimmune haematological disorders[J]. Br.J.Haematol,2008,141:149-169.
[12] Barcellini W,Zaja F,Zaninoni A,et al. Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia:clinical efficacy and biologic studies[J].Blood,2012,119:3691-3697.